NYSE:INO
Inovio Pharmaceuticals Stock News
$11.00
+0.0400 (+0.365%)
At Close: May 24, 2024
Inovio Coronavirus Vaccine To Enter Mid-To-Late Stage Testing In September
12:00am, Tuesday, 11'th Aug 2020
Inovio Pharmaceuticals Inc (NASDAQ: INO) said during the earnings call Monday it expected its COVID-19 vaccine to enter mid-to-late stage human trials in September, Reuters reported.
Inovio Pharmaceuticals, Inc. (INO) CEO J.
09:35pm, Monday, 10'th Aug 2020
Inovio Pharmaceuticals, Inc. (INO) CEO J.
Inovio Pharma stock fluctuates after results, vaccine update
09:17pm, Monday, 10'th Aug 2020
Inovio Pharmaceuticals Inc. shares fluctuated between slight gains and losses in the extended session Monday after the biotech company reported results that fell short of Wall Street estimates while
INOVIO Reports Second Quarter 2020 Financial Results; Provides DNA Medicines Clinical Program Mid-Year Update
08:05pm, Monday, 10'th Aug 2020
INOVIO (NASDAQ:INO), a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today reported fina
Inovio Pharma stock fluctuates after results, vaccine update
05:17pm, Monday, 10'th Aug 2020
Inovio Pharmaceuticals Inc. INO, -6.08% shares fluctuated between slight gains and losses in the extended session Monday after the biotech company reported results that fell short of Wall Street estim
T Cell Responses To Coronavirus Vaccines Are In The Interest Of National Security
04:39pm, Monday, 10'th Aug 2020
COVID-19 has weakened the US economy more than China's.
INOVIO Reports Second Quarter 2020 Financial Results; Provides DNA Medicines Clinical Program Mid-Year Update
04:05pm, Monday, 10'th Aug 2020
PLYMOUTH MEETING, Pa., Aug. 10, 2020 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people fro
Zacks: Analysts Anticipate Inovio Pharmaceuticals Inc (NASDAQ:INO) Will Post Quarterly Sales of $2.08 Million
07:36pm, Sunday, 09'th Aug 2020
Equities analysts expect that Inovio Pharmaceuticals Inc (NASDAQ:INO) will post sales of $2.08 million for the current quarter, Zacks reports. Four analysts have provided estimates for Inovio Pharmace
The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings
12:00am, Sunday, 09'th Aug 2020
Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and continuing coronavirus...
Is It Too Late To Buy Inovio Pharmaceuticals Stock?
07:14am, Saturday, 08'th Aug 2020
There's an easy and emphatic answer.
Earnings Outlook for Inovio Pharmaceuticals
03:01pm, Friday, 07'th Aug 2020
On Monday, August 10, Inovio Pharmaceuticals (NASDAQ: INO) will release its latest earnings report. Check out Benzinga's preview to understand the implications.Earnings and Revenue Analysts covering I
Earnings Outlook for Inovio Pharmaceuticals
11:01am, Friday, 07'th Aug 2020
On Monday, August 10, Inovio Pharmaceuticals (NASDAQ: INO) will release its latest earnings report.
Hahn: FDA won’t make regulatory decisions based on preprints or news releases
10:15am, Thursday, 06'th Aug 2020
The COVID-19 pandemic has upended the long standing model for publishing clinical data as researchers and drugmakers race to share the latest findings about...
Why Inovio Fell 27.9% in July
09:00am, Thursday, 06'th Aug 2020
Lack of detail in a clinical trial report weighed on the shares.
It’s Time to Get Serious About Inovio Pharmaceuticals
08:29am, Thursday, 06'th Aug 2020
Due to the government's desire to develop multiple vaccine candidates and several intriguing catalysts, INO stock deserves serious consideration.
The post It’s Time to Get Serious About Inovio Pharm
